The role of cytochrome P450 enzyme genetic variants in cannabis hyperemesis syndrome-A case report

Basic Clin Pharmacol Toxicol. 2021 Jul;129(1):82-85. doi: 10.1111/bcpt.13581. Epub 2021 Mar 27.

Maxim Kuzin¹, Franziskos Xepapadakos¹, Isabel Scharrer¹, Marc Augsburger², Chin-Bin Eap^{3

4

5

6}, Georgios Schoretsanitis^{7

8}

¹ Clienia Schloessli, Private Psychiatric Hospital and Academic Teaching Hospital of the University of Zurich, Oetwil am See, Switzerland.
² Forensic Toxicology and Chemistry Unit, CURML, Geneva University Hospitals, Lausanne University Hospital, Lausanne, Switzerland.
³ Department of Psychiatry, Unit of Pharmacogenetics and Clinical Psychopharmacology Centre for Psychiatric Neuroscience, Lausanne University Hospital, Prilly, University of Lausanne, Lausanne, Switzerland.
⁴ Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
⁵ School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
⁶ Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
⁷ Psychiatry Research, Northwell Health, The Zucker Hillside Hospital, Glen Oaks, NY, USA.
⁸ University Hospital of Psychiatry Zurich, Zurich, Switzerland.

No abstract available

Publication types